Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,1.3634818960228869e-62,82.35226890756303,11731.099986194984,"['RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS6KA6', 'RPS17', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPS11', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'RPS20', 'FAU', 'RPS21', 'RPS24', 'RPS23']",5.862972152898414e-60,0,0,78
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,2.800017521218032e-40,34.51813271604938,3143.6967575101066,"['COX7B', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'COX8A', 'NDUFC1', 'COX6B1', 'NDUFS6', 'NDUFS5', 'NDUFS3', 'SLC25A5', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'ATP5MC1', 'UCP3', 'COX11', 'NDUFV1', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'ATP5F1D', 'ATP5F1E', 'UQCRQ', 'NDUFAB1', 'ATP5PO']",6.020037670618769e-38,0,0,57
3,Oxidative phosphorylation WP623,2.871568006335116e-22,28.529901589704767,1415.1405729819392,"['NDUFB9', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'ATP5MC1', 'NDUFV1', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'ATP5PO']",4.1159141424136666e-20,0,0,32
4,Mitochondrial complex I assembly model OXPHOS system WP4324,1.7879216588451546e-18,22.120587002096435,903.9683573461451,"['NDUFB9', 'NDUFA13', 'NDUFB8', 'NDUFB7', 'DMAC1', 'NDUFB10', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'TMEM186', 'NDUFV1', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF4', 'NDUFAB1', 'NDUFS3', 'TMEM126B']",1.9220157832585413e-16,0,0,28
5,Nonalcoholic fatty liver disease WP4396,1.0496535980456156e-17,6.179057690237864,241.57326575623424,"['NDUFA13', 'COX7B', 'NDUFA11', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'MLX', 'UQCRFS1', 'COX8A', 'NDUFC1', 'COX6B1', 'NDUFS6', 'DDIT3', 'NDUFS5', 'NDUFS3', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'CYC1', 'NDUFV1', 'NDUFA8', 'XBP1', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'UQCRQ', 'NDUFAB1', 'CYCS', 'BAX']",9.027020943192295e-16,0,0,49
6,Mitochondrial CIV Assembly WP4922,1.1447998111862904e-16,38.950413223140494,1429.718997677313,"['COX8A', 'COA3', 'COX7B', 'SURF1', 'COX16', 'PET100', 'NDUFA4', 'TACO1', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'PET117', 'COX6B1', 'SCO2', 'COX11', 'COX14', 'COX20']",8.204398646835081e-15,0,0,22
7,Cellular Proteostasis WP4918,3.864558513042164e-06,inf,inf,"['VBP1', 'PFDN1', 'PFDN2', 'PFDN4', 'PFDN5', 'PFDN6']",0.00023739430865830433,0,0,6
8,Mitochondrial complex III assembly WP4921,6.9992908237549295e-06,18.690458488228003,221.8501673575162,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",0.00037621188177682744,0,0,8
9,Pyrimidine metabolism WP4022,0.0010837936853259952,2.9253861484803187,19.9724529314908,"['POLR3GL', 'NME2', 'NME3', 'NME1', 'NT5C', 'POLE4', 'POLD4', 'ZNRD1', 'POLE3', 'TK1', 'POLR2I', 'DCTPP1', 'POLR2J', 'POLR2K', 'POLR2L']",0.051781253854464214,0,0,15
10,mRNA Processing WP411,0.001667740534229311,2.7708284163323107,17.723009739203302,"['DHX8', 'CELF1', 'NCBP2', 'CELF2', 'LSM2', 'LSM7', 'SNRPD1', 'SNRPG', 'SRSF3', 'SNRPE', 'SNRPB2', 'SNRPF', 'DNAJC8', 'HNRNPA1', 'SRSF9']",0.07171284297186037,0,0,15
11,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.0030006782427001947,13.977761304670127,81.19565435561631,"['COX8A', 'CYP2C8', 'GSTP1', 'COX5A']",0.11729924039646217,0,0,4
12,Sleep regulation WP3591,0.009087544171073542,3.2934178876011373,15.481865372270335,"['CACNA1I', 'AHCY', 'STAR', 'IL18', 'CRH', 'DRD1', 'BTBD9', 'HCRTR1']",0.30308131219673584,0,0,8
13,Proteasome Degradation WP183,0.009162923391994338,3.0003188775510203,14.079266372453969,"['PSMB6', 'PSMC5', 'PSMD7', 'H2AFZ', 'PSMC1', 'HLA-B', 'PSMB10', 'PSMA7', 'PSMB8']",0.30308131219673584,0,0,9
14,Base Excision Repair WP4752,0.018802443649000446,3.495916852264291,13.891964043328661,"['POLE4', 'POLD4', 'NTHL1', 'TDG', 'APEX1', 'POLE3']",0.5775036263621566,0,0,6
15,Nucleotide Excision Repair WP4753,0.02419870942267622,2.8795996853421904,10.716303460047246,"['POLE4', 'POLD4', 'RFC2', 'POLE3', 'RAD23A', 'MNAT1', 'GTF2H5']",0.665269158259076,0,0,7
16,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.027750800355769156,4.657276995305164,16.69396559988646,"['RRAS2', 'MAPK1', 'BRAF', 'HRAS']",0.665269158259076,0,0,4
17,Cytosine methylation WP3585,0.02939561396958708,6.982962962962963,24.62828051042501,"['TDG', 'TET3', 'IDH2']",0.665269158259076,0,0,3
18,Dual hijack model of Vif in HIV infection WP3300,0.02939561396958708,6.982962962962963,24.62828051042501,"['ELOB', 'ELOC', 'RUNX1']",0.665269158259076,0,0,3
19,Purine metabolism WP4792,0.02939561396958708,6.982962962962963,24.62828051042501,"['PNP', 'ITPA', 'APRT']",0.665269158259076,0,0,3
20,Heme Biosynthesis WP561,0.04325805483287871,13.958549222797927,43.837826393511854,"['UROD', 'HMBS']",0.8857601703875163,0,0,2
21,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.04325805483287871,13.958549222797927,43.837826393511854,"['ELOB', 'ELOC']",0.8857601703875163,0,0,2
22,BDNF-TrkB Signaling WP3676,0.048904775117231195,2.620824053452116,7.909333114544468,"['NTRK2', 'TRPC6', 'DLG4', 'MAPK1', 'BRAF', 'HRAS']",0.9558660591095188,0,0,6
23,DNA Mismatch Repair WP531,0.05334337276879551,3.492216456634544,10.235705748854397,"['POLE4', 'POLD4', 'RFC2', 'POLE3']",0.9596594927357066,0,0,4
24,DNA Repair Pathways Full Network WP4946,0.05356239029222548,1.825503355704698,5.343080614698855,"['POLE4', 'POLD4', 'DCLRE1C', 'CENPX', 'NTHL1', 'RFC2', 'TDG', 'APEX1', 'POLE3', 'RAD23A', 'MNAT1', 'GTF2H5']",0.9596594927357066,0,0,12
25,Macrophage markers WP4146,0.0679179530569759,4.188888888888889,11.26582764302388,"['CD163', 'CD14', 'CD68']",0.9996837755714765,0,0,3
26,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.0679179530569759,4.188888888888889,11.26582764302388,"['EIF2S2', 'EIF3D', 'EIF1']",0.9996837755714765,0,0,3
27,Intraflagellar transport proteins binding to dynein WP4532,0.06964231558218231,3.1038629437443372,8.269879394355158,"['IFT22', 'DYNLT1', 'DYNLRB2', 'DYNLL1']",0.9996837755714765,0,0,4
28,Peroxiredoxin 2 induced ovarian failure WP4873,0.0793703621621222,6.978534418948927,17.68102592496177,"['STAR', 'BAX']",0.9996837755714765,0,0,2
29,Pilocytic astrocytoma WP2253,0.0793703621621222,6.978534418948927,17.68102592496177,"['NF1', 'BRAF']",0.9996837755714765,0,0,2
30,Selenium Micronutrient Network WP15,0.08550299668482904,1.709471766848816,4.203939558549537,"['SELENOM', 'PRDX5', 'GPX4', 'SELENOS', 'ALOX5', 'ALOX5AP', 'DIO2', 'SELENOW', 'TXN', 'SELENOK', 'SELENOH']",0.9996837755714765,0,0,11
31,Ciliary landscape WP4352,0.09251499441377323,1.4276436630805562,3.3983409125495276,"['RALB', 'DYNLT1', 'NDUFA5', 'SSNA1', 'EXOC6B', 'COPS7A', 'MYL6B', 'DYNLL1', 'COX6C', 'LSM4', 'EHBP1', 'MYL6', 'COPS6', 'IFT22', 'PSMD7', 'TMED1', 'EXOC6', 'DYNLRB2', 'SNRPB2', 'DCAF11', 'GLA']",0.9996837755714765,0,0,21
32,Eukaryotic Transcription Initiation WP405,0.09603576881134107,2.3281404549950544,5.45491355851828,"['GTF2A2', 'POLR2I', 'MNAT1', 'POLR2J', 'POLR2K']",0.9996837755714765,0,0,5
33,Cytosolic DNA-sensing pathway WP4655,0.09768566138329358,1.9564635958395244,4.5507352872654305,"['RNF125', 'POLR3GL', 'TRADD', 'IL18', 'IKBKE', 'POLR2K', 'POLR2L']",0.9996837755714765,0,0,7
34,Purine metabolism and related disorders WP4224,0.12046393966762695,2.9914285714285715,6.3310738673227975,"['PNP', 'ITPA', 'APRT']",0.9996837755714765,0,0,3
35,Mitochondrial CII Assembly WP4920,0.12547502739326652,inf,inf,['SDHAF1'],0.9996837755714765,0,0,1
36,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.1313733982728847,2.327155917963924,4.723455459168431,"['H2AFJ', 'H2AFZ', 'MAPK1', 'HIST1H3E']",0.9996837755714765,0,0,4
37,IL-18 signaling pathway WP4754,0.14555651549883947,1.3020456016938773,2.5092903635063166,"['NRN1', 'TOMM40', 'IMP3', 'CD81', 'NCF2', 'COX17', 'IL18', 'TNFAIP3', 'TNFRSF11B', 'NDUFC1', 'BPGM', 'RND2', 'GATA1', 'GRM7', 'RASA3', 'NACA', 'TMSB4X', 'CYCS', 'MAPK1', 'BAX', 'PTPN7', 'RPS11', 'NOX1', 'ITM2C']",0.9996837755714765,0,0,24
38,ERK Pathway in Huntington's Disease WP3853,0.15087456868117757,2.6172222222222223,4.949969291828939,"['NTRK2', 'MAPK1', 'HRAS']",0.9996837755714765,0,0,3
39,Fatty acid transporters WP5061,0.15087456868117757,2.6172222222222223,4.949969291828939,"['FABP6', 'FABP7', 'DBI']",0.9996837755714765,0,0,3
40,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.15087456868117757,2.6172222222222223,4.949969291828939,"['ZAP70', 'CD4', 'HLA-DRB1']",0.9996837755714765,0,0,3
41,Modulators of TCR signaling and T cell activation WP5072,0.15747150396537074,1.6858892247783983,3.1163843794029638,"['ZAP70', 'FIBP', 'NDUFB10', 'TNFAIP3', 'RHOH', 'ELOB', 'RNF7']",0.9996837755714765,0,0,7
42,TCA cycle in senescence WP5050,0.16753004857773576,3.4885270170244262,6.2325763766906395,"['ME1', 'BRAF']",0.9996837755714765,0,0,2
43,MET in type 1 papillary renal cell carcinoma WP4205,0.17455824561469963,1.6295195641406637,2.844321196601531,"['RPL11', 'MAPK1', 'BRAF', 'HRAS', 'PTK2', 'CRKL', 'PAK4']",0.9996837755714765,0,0,7
44,CAMKK2  Pathway WP4874,0.17463226989738073,1.8372247384038731,3.2060909750448077,"['CHRM3', 'FIS1', 'MAP1LC3A', 'STIM1', 'MAPK1']",0.9996837755714765,0,0,5
45,Corticotropin-releasing hormone signaling pathway WP2355,0.18316807882037056,1.496811224489796,2.5406141546869825,"['POMC', 'STAR', 'IL18', 'CRH', 'MAPK1', 'FOSB', 'BRAF', 'ACACA', 'PTK2']",0.9996837755714765,0,0,9
46,Overview of nanoparticle effects WP3287,0.1833849767138952,2.3261728395061727,3.945579090589397,"['COL4A1', 'BAX', 'PTK2']",0.9996837755714765,0,0,3
47,Microglia Pathogen Phagocytosis Pathway WP3937,0.20603751717979824,1.6111015932842214,2.5450523609251623,"['NCF2', 'ARPC1B', 'NCF4', 'ITGB2', 'RAC3', 'CYBA']",0.9996837755714765,0,0,6
48,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.21585725952122342,2.7905255366395263,4.278260531728807,"['HSD11B2', 'STAR']",0.9996837755714765,0,0,2
49,Iron metabolism in placenta WP2007,0.21585725952122342,2.7905255366395263,4.278260531728807,"['HEPHL1', 'FTH1']",0.9996837755714765,0,0,2
50,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.21585725952122342,2.7905255366395263,4.278260531728807,"['MAPK1', 'PTK2']",0.9996837755714765,0,0,2
51,Nanoparticle triggered regulated necrosis WP2513,0.21585725952122342,2.7905255366395263,4.278260531728807,"['TRADD', 'FTL']",0.9996837755714765,0,0,2
52,Kallmann's Syndrome WP5074,0.21750778040321345,2.0933333333333333,3.1934232422470825,"['MAPK1', 'GNRH1', 'FRS2']",0.9996837755714765,0,0,3
53,Nanomaterial induced apoptosis WP2507,0.21750778040321345,2.0933333333333333,3.1934232422470825,"['ENDOG', 'BAX', 'CYCS']",0.9996837755714765,0,0,3
54,SARS-CoV-2 mitochondrial interactions WP5038,0.23666610689256812,1.7446256486286138,2.514188680572157,"['NDUFB9', 'PHB', 'IKBKE', 'NOX1']",0.9996837755714765,0,0,4
55,7q11.23 copy number variation syndrome WP4932,0.2455911828056786,1.3428604158313764,1.8854928311734074,"['RFC2', 'ATP5MC2', 'FZD9', 'ATP5PO', 'ATP5MC3', 'VPS37B', 'ATP5F1D', 'ACACA', 'ATP5F1E', 'ATP5MC1']",0.9996837755714765,0,0,10
56,Regulation of Actin Cytoskeleton WP51,0.24711286518486153,1.2700115418562021,1.7753619648467531,"['CHRM3', 'CHRM5', 'BRK1', 'RRAS2', 'BRAF', 'ARHGAP35', 'PTK2', 'SSH1', 'FGF17', 'TMSB4X', 'RAC3', 'MAPK1', 'CD14', 'PAK4']",0.9996837755714765,0,0,14
57,Cancer immunotherapy by PD-1 blockade WP4585,0.2527798237531126,1.9028282828282828,2.6168387764782572,"['ZAP70', 'HLA-DRB1', 'BATF']",0.9996837755714765,0,0,3
58,Ferroptosis WP4313,0.2702070750723812,1.5170623145400592,1.985177179941494,"['MAP1LC3A', 'GPX4', 'FTH1', 'SAT2', 'FTL']",0.9996837755714765,0,0,5
59,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.2702070750723812,1.5170623145400592,1.985177179941494,"['NTRK2', 'DLG4', 'NF1', 'MAPK1', 'HRAS']",0.9996837755714765,0,0,5
60,TP53 network WP1742,0.288771896725941,1.744074074074074,2.166346127238706,"['SUMO1', 'GADD45A', 'BAX']",0.9996837755714765,0,0,3
61,MAPK Cascade WP422,0.2951416329131382,1.5504488921835105,1.8920126688464625,"['RASA3', 'MAPK1', 'BRAF', 'HRAS']",0.9996837755714765,0,0,4
62,TNF-alpha signaling pathway WP231,0.3004534069218071,1.282024416909621,1.541586399351134,"['TRADD', 'TNFAIP3', 'MAPK1', 'BAX', 'CYBA', 'TXN', 'BTRC', 'HRAS', 'NOX1']",0.9996837755714765,0,0,9
63,RalA downstream regulated genes WP2290,0.31446189708103184,1.9928095590567834,2.305466162051534,"['RAC3', 'HRAS']",0.9996837755714765,0,0,2
64,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.31446189708103184,1.9928095590567834,2.305466162051534,"['IDH2', 'IDH3B']",0.9996837755714765,0,0,2
65,Copper homeostasis WP3286,0.3250512790553681,1.4686902578908354,1.6504734693247085,"['SCO2', 'COX17', 'COX11', 'ATOX1']",0.9996837755714765,0,0,4
66,Signaling of Hepatocyte Growth Factor Receptor WP313,0.3250512790553681,1.4686902578908354,1.6504734693247085,"['MAPK1', 'HRAS', 'PTK2', 'CRKL']",0.9996837755714765,0,0,4
67,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.3311954556777428,3.4866863905325443,3.85295086213312,['MAP1LC3A'],0.9996837755714765,0,0,1
68,Mevalonate pathway WP3963,0.3311954556777428,3.4866863905325443,3.85295086213312,['PMVK'],0.9996837755714765,0,0,1
69,mir-124 predicted interactions with cell cycle and differentiation  WP3595,0.3311954556777428,3.4866863905325443,3.85295086213312,['CTDSP1'],0.9996837755714765,0,0,1
70,Mitochondrial fatty acid synthesis pathway WP4317,0.3311954556777428,3.4866863905325443,3.85295086213312,['ACACA'],0.9996837755714765,0,0,1
71,The alternative pathway of fetal androgen synthesis WP4524,0.3311954556777428,3.4866863905325443,3.85295086213312,['STAR'],0.9996837755714765,0,0,1
72,Amyotrophic lateral sclerosis (ALS) WP2447,0.3551350747360374,1.3951074870274278,1.4442948888826073,"['TOMM40', 'SLC1A2', 'BAX', 'NEFH']",0.9996837755714765,0,0,4
73,Gastric Cancer Network 2 WP2363,0.3614014447739771,1.4946031746031747,1.5211561498024608,"['AHCTF1', 'S100A6', 'COL9A3']",0.9996837755714765,0,0,3
74,Cytokines and Inflammatory Response WP530,0.3629613762909427,1.7435233160621761,1.7669891379492142,"['CD4', 'HLA-DRB1']",0.9996837755714765,0,0,2
75,"GPCRs, Class B Secretin-like WP334",0.3629613762909427,1.7435233160621761,1.7669891379492142,"['ADGRE1', 'ADGRL2']",0.9996837755714765,0,0,2
76,LTF danger signal response pathway WP4478,0.3629613762909427,1.7435233160621761,1.7669891379492142,"['MAPK1', 'CD14']",0.9996837755714765,0,0,2
77,Methionine De Novo and Salvage Pathway WP3580,0.3629613762909427,1.7435233160621761,1.7669891379492142,"['AHCY', 'TXN']",0.9996837755714765,0,0,2
78,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.3629613762909427,1.7435233160621761,1.7669891379492142,"['MAPK1', 'PTK2']",0.9996837755714765,0,0,2
79,Serotonin and anxiety WP3947,0.3629613762909427,1.7435233160621761,1.7669891379492142,"['POMC', 'CRH']",0.9996837755714765,0,0,2
80,Kit receptor signaling pathway WP304,0.3637228602902174,1.2684079098332997,1.2828209229854328,"['DOK1', 'RPS6', 'GRB10', 'MAPK1', 'HRAS', 'CRKL']",0.9996837755714765,0,0,6
81,Alpha 6 Beta 4 signaling pathway WP244,0.38520568900072777,1.3285325991033923,1.26739064626141,"['LAMA5', 'MAPK1', 'HRAS', 'PTK2']",0.9996837755714765,0,0,4
82,Bladder cancer WP2828,0.38520568900072777,1.3285325991033923,1.26739064626141,"['DAPK1', 'MAPK1', 'BRAF', 'HRAS']",0.9996837755714765,0,0,4
83,Nephrotic syndrome WP4758,0.38520568900072777,1.3285325991033923,1.26739064626141,"['TRPC6', 'TTC21B', 'PTPRO', 'PAX2']",0.9996837755714765,0,0,4
84,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.3973350491544475,1.1909361069836553,1.0992047317333955,"['RALB', 'GADD45A', 'RAC3', 'MAPK1', 'CYCS', 'BAX', 'BRAF']",0.9996837755714765,0,0,7
85,Glycosylation and related congenital defects WP4521,0.3973894673879693,1.3948148148148147,1.2871887459537237,"['DPM2', 'DPM3', 'MPDU1']",0.9996837755714765,0,0,3
86,Nanoparticle-mediated activation of receptor signaling WP2643,0.3973894673879693,1.3948148148148147,1.2871887459537237,"['MAPK1', 'HRAS', 'PTK2']",0.9996837755714765,0,0,3
87,Parkinson's disease pathway WP2371,0.3973894673879693,1.3948148148148147,1.2871887459537237,"['ATXN2', 'CYCS', 'PARK7']",0.9996837755714765,0,0,3
88,Photodynamic therapy-induced unfolded protein response WP3613,0.3973894673879693,1.3948148148148147,1.2871887459537237,"['NARS', 'XBP1', 'DDIT3']",0.9996837755714765,0,0,3
89,"Relationship between inflammation, COX-2 and EGFR WP4483",0.3973894673879693,1.3948148148148147,1.2871887459537237,"['MAPK1', 'BRAF', 'HRAS']",0.9996837755714765,0,0,3
90,Type 2 papillary renal cell carcinoma WP4241,0.3973894673879693,1.3948148148148147,1.2871887459537237,"['SETD2', 'ELOB', 'ELOC']",0.9996837755714765,0,0,3
91,Genotoxicity pathway WP4286,0.400248117820996,1.24549597286986,1.1404640816729126,"['AMER1', 'RPS27', 'GADD45A', 'RAPGEF2', 'TRIAP1']",0.9996837755714765,0,0,5
92,p53 transcriptional gene network WP4963,0.400248117820996,1.24549597286986,1.1404640816729126,"['SIVA1', 'NCF2', 'GADD45A', 'BAX', 'TNFRSF10D']",0.9996837755714765,0,0,5
93,VEGFA-VEGFR2 Signaling Pathway WP3888,0.4024735304365188,1.0584794957396981,0.9633496536271337,"['RPL5', 'SET', 'NCF2', 'TXN', 'RPL10A', 'HDAC9', 'ACACA', 'RPL7', 'PNP', 'RPL18A', 'TMSB4X', 'FAM120A', 'GRB10', 'RPLP2', 'MAPK1', 'ELOC', 'RPS11', 'TMSB10', 'ACP1', 'HRAS', 'SDF2L1', 'SSR4', 'RPS6', 'IDH2', 'SARS', 'RPL13A', 'FRS2', 'PTK2', 'DOK1', 'CYP2C8', 'RHOJ', 'CYCS', 'RPL27', 'RPL26', 'ALDOA', 'EIF3D', 'PTMA']",0.9996837755714765,0,0,37
94,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.4100917633241114,1.5496340159552595,1.3813039847946686,"['RPS6', 'ACACA']",0.9996837755714765,0,0,2
95,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.4150919482175026,1.2680099737179056,1.1149043900808313,"['PPP1R14B', 'XBP1', 'MAP1LC3A', 'DDIT3']",0.9996837755714765,0,0,4
96,IL-2 signaling pathway WP49,0.4150919482175026,1.2680099737179056,1.1149043900808313,"['RPS6', 'MAPK1', 'HRAS', 'CRKL']",0.9996837755714765,0,0,4
97,Splicing factor NOVA regulated synaptic proteins WP4148,0.4150919482175026,1.2680099737179056,1.1149043900808313,"['KCNQ2', 'GRIK2', 'ANK3', 'STX2']",0.9996837755714765,0,0,4
98,"Degradation pathway of sphingolipids, including diseases WP4153",0.4151371252888389,2.3242110453648914,2.043321752329718,['GLA'],0.9996837755714765,0,0,1
99,Metabolism of alpha-linolenic acid WP4586,0.4151371252888389,2.3242110453648914,2.043321752329718,['ALOX5'],0.9996837755714765,0,0,1
100,Hematopoietic Stem Cell Differentiation WP2849,0.42635795258639647,1.2024199324670009,1.025034159900991,"['RHOH', 'FOSB', 'ACVR1B', 'GATA1', 'RUNX1']",0.9996837755714765,0,0,5
101,Integrin-mediated Cell Adhesion WP185,0.43051578788111206,1.1209343112244898,0.9446912469878261,"['SHC3', 'ITGB2', 'RAC3', 'MAPK1', 'BRAF', 'ITGAE', 'HRAS', 'PTK2', 'PAK4']",0.9996837755714765,0,0,9
102,Disruption of postsynaptic signaling by CNV WP4875,0.4327987228663568,1.3075,1.0950083717801773,"['DLG2', 'MAPK1', 'DLGAP1']",0.9996837755714765,0,0,3
103,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.4327987228663568,1.3075,1.0950083717801773,"['MAP1LC3A', 'ACACA', 'FTL']",0.9996837755714765,0,0,3
104,Acute viral myocarditis WP4298,0.44043781850577723,1.1353018418051763,0.9309316214328833,"['CD4', 'ENDOG', 'ITGB2', 'RAC3', 'MAPK1', 'CYCS', 'BAX']",0.9996837755714765,0,0,7
105,ErbB signaling pathway WP673,0.44527051863751593,1.115836431226766,0.9027934351810284,"['SHC3', 'NRG3', 'MAPK1', 'BRAF', 'HRAS', 'PTK2', 'CRKL', 'PAK4']",0.9996837755714765,0,0,8
106,Complement system WP2806,0.449241354416897,1.1011513157894737,0.8811357749189819,"['LAMA5', 'FKBP2', 'FCGR3A', 'RPS19', 'ITGB2', 'F11', 'CD59', 'VSIG4', 'TXN']",0.9996837755714765,0,0,9
107,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.4554331022026845,1.3945225758697262,1.096800986370885,"['MAPK1', 'BRAF']",0.9996837755714765,0,0,2
108,22q11.2 copy number variation syndrome WP4657,0.4651381046737671,1.093840658940156,0.8372485215216265,"['RANBP1', 'P2RX6', 'MRPL40', 'THAP7', 'LRRC74B', 'DGCR6L', 'CRKL', 'PAK4']",0.9996837755714765,0,0,8
109,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.4651381046737671,1.093840658940156,0.8372485215216265,"['SHC3', 'RPS6', 'NF1', 'RRAS2', 'MAPK1', 'BAX', 'BRAF', 'HRAS']",0.9996837755714765,0,0,8
110,NO/cGMP/PKG mediated Neuroprotection WP4008,0.47371169397247775,1.1620953792933038,0.8682669801831517,"['DLG4', 'CYCS', 'CNGA3', 'CNGB1']",0.9996837755714765,0,0,4
111,3q29 copy number variation syndrome WP4906,0.4777930686215037,1.1246051498037715,0.8306081174485012,"['DYNLT1', 'NCBP2', 'PIGM', 'DYNLRB2', 'DYNLL1']",0.9996837755714765,0,0,5
112,Biotin Metabolism (including IEMs) WP5031,0.48855006489623803,1.742973372781065,1.248515053363415,['ACACA'],0.9996837755714765,0,0,1
113,"Cerebral organic acidurias, including diseases WP4519",0.48855006489623803,1.742973372781065,1.248515053363415,['IDH2'],0.9996837755714765,0,0,1
114,FTO Obesity Variant Mechanism WP3407,0.48855006489623803,1.742973372781065,1.248515053363415,['FTO'],0.9996837755714765,0,0,1
115,MED and Pseudoachondroplasia genes WP4789,0.48855006489623803,1.742973372781065,1.248515053363415,['COL9A3'],0.9996837755714765,0,0,1
116,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.48855006489623803,1.742973372781065,1.248515053363415,['PMVK'],0.9996837755714765,0,0,1
117,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.48855006489623803,1.742973372781065,1.248515053363415,['MAPK1'],0.9996837755714765,0,0,1
118,Trans-sulfuration pathway WP2333,0.48855006489623803,1.742973372781065,1.248515053363415,['AHCY'],0.9996837755714765,0,0,1
119,Valproic acid pathway WP3871,0.48855006489623803,1.742973372781065,1.248515053363415,['HSD17B10'],0.9996837755714765,0,0,1
120,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.4986922301891196,1.2676132157997444,0.8819623626395717,"['MAPK1', 'HRAS']",0.9996837755714765,0,0,2
121,Type II diabetes mellitus WP1584,0.4986922301891196,1.2676132157997444,0.8819623626395717,"['SURF1', 'MAPK1']",0.9996837755714765,0,0,2
122,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.5010440092978851,1.1619753086419753,0.8029962124952862,"['MAPK1', 'BAX', 'BRAF']",0.9996837755714765,0,0,3
123,PPAR signaling pathway WP3942,0.5029363077363083,1.0893453264094954,0.7486980466775376,"['FABP6', 'FABP7', 'ME1', 'DBI', 'CPT1B']",0.9996837755714765,0,0,5
124,Melanoma WP4685,0.5035030048313495,1.0725829478613442,0.735969520846956,"['GADD45A', 'NF1', 'MAPK1', 'BAX', 'BRAF', 'HRAS']",0.9996837755714765,0,0,6
125,Ras signaling WP4223,0.5064156618787388,1.0252352061900993,0.6975674514677678,"['NTRK2', 'SHC3', 'RALB', 'RRAS2', 'RASAL2', 'RASAL3', 'ZAP70', 'GNG10', 'GNG3', 'RASA3', 'NF1', 'RAC3', 'MAPK1', 'HRAS', 'PAK4']",0.9996837755714765,0,0,15
126,Neural Crest Cell Migration in Cancer WP4565,0.5299663961517023,1.0724753378571021,0.6809592905611891,"['NTRK2', 'TRIO', 'F2RL2', 'PAK4']",0.9996837755714765,0,0,4
127,Vitamin D-sensitive calcium signaling in depression WP4698,0.5335548928652596,1.100701754385965,0.6914534911398372,"['GPX4', 'KCNQ2', 'PVALB']",0.9996837755714765,0,0,3
128,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.5396776073441443,1.161855415741426,0.7166130652542706,"['CD63', 'CD81']",0.9996837755714765,0,0,2
129,Fatty Acid Biosynthesis WP357,0.5396776073441443,1.161855415741426,0.7166130652542706,"['ACAA2', 'ACACA']",0.9996837755714765,0,0,2
130,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.552754027423671,1.3942307692307692,0.826558799052366,['SST'],0.9996837755714765,0,0,1
131,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.552754027423671,1.3942307692307692,0.826558799052366,['AHCY'],0.9996837755714765,0,0,1
132,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.552754027423671,1.3942307692307692,0.826558799052366,['VEGFB'],0.9996837755714765,0,0,1
133,Non-homologous end joining WP438,0.552754027423671,1.3942307692307692,0.826558799052366,['DCLRE1C'],0.9996837755714765,0,0,1
134,Serotonin and anxiety-related events WP3944,0.552754027423671,1.3942307692307692,0.826558799052366,['CRH'],0.9996837755714765,0,0,1
135,Aryl Hydrocarbon Receptor Netpath WP2586,0.5569588578049335,1.0326442083299014,0.6043693825531398,"['AIP', 'NF1', 'MAPK1', 'HRAS']",0.9996837755714765,0,0,4
136,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.5569588578049335,1.0326442083299014,0.6043693825531398,"['RNF125', 'TRADD', 'PIN1', 'IKBKE']",0.9996837755714765,0,0,4
137,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.5569588578049335,1.0326442083299014,0.6043693825531398,"['NDUFA13', 'COPS6', 'ACAP1', 'IL18']",0.9996837755714765,0,0,4
138,Translation Factors WP107,0.5569588578049335,1.0326442083299014,0.6043693825531398,"['EEF1B2', 'EIF2S2', 'EIF3D', 'EIF1']",0.9996837755714765,0,0,4
139,Prion disease pathway WP3995,0.5648304155648223,1.0455555555555556,0.597252430594155,"['MAPK1', 'PTK2', 'BATF']",0.9996837755714765,0,0,3
140,Non-small cell lung cancer WP4255,0.5903730107816682,0.9723934324338322,0.5124520391972034,"['GADD45A', 'MAPK1', 'CYCS', 'BAX', 'BRAF', 'HRAS']",0.9996837755714765,0,0,6
141,Histone Modifications WP2369,0.5947868721572797,0.9956613756613757,0.517297994118789,"['SETD2', 'SET', 'HIST1H3E']",0.9996837755714765,0,0,3
142,p38 MAPK Signaling Pathway WP400,0.5947868721572797,0.9956613756613757,0.517297994118789,"['TRADD', 'DDIT3', 'HRAS']",0.9996837755714765,0,0,3
143,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.5979908970728357,0.9678948236069898,0.4976719159445244,"['TMSB4X', 'FZD9', 'MAPK1', 'NEFH', 'PTK2']",0.9996837755714765,0,0,5
144,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.5979908970728357,0.9678948236069898,0.4976719159445244,"['LAMA5', 'TRPC6', 'PTPRO', 'PAX2', 'PTK2']",0.9996837755714765,0,0,5
145,Bile acids synthesis and enterohepatic circulation  WP4389,0.6089034452706019,1.1617357001972386,0.5763319346060884,['MAPK1'],0.9996837755714765,0,0,1
146,Codeine and Morphine Metabolism WP1604,0.6089034452706019,1.1617357001972386,0.5763319346060884,['CYP2C8'],0.9996837755714765,0,0,1
147,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.6089034452706019,1.1617357001972386,0.5763319346060884,['CYP2C8'],0.9996837755714765,0,0,1
148,Homologous recombination WP186,0.6089034452706019,1.1617357001972386,0.5763319346060884,['POLD4'],0.9996837755714765,0,0,1
149,Insulin signaling in adipocytes (diabetic condition) WP3635,0.6089034452706019,1.1617357001972386,0.5763319346060884,['RPS6'],0.9996837755714765,0,0,1
150,Insulin signaling in adipocytes (normal condition) WP3634,0.6089034452706019,1.1617357001972386,0.5763319346060884,['RPS6'],0.9996837755714765,0,0,1
151,Leptin and adiponectin WP3934,0.6089034452706019,1.1617357001972386,0.5763319346060884,['ACACA'],0.9996837755714765,0,0,1
152,Nanomaterial-induced inflammasome activation WP3890,0.6089034452706019,1.1617357001972386,0.5763319346060884,['NOX1'],0.9996837755714765,0,0,1
153,Leptin signaling pathway WP2034,0.6108187053790749,0.9501923466288722,0.4684021458763147,"['RPS6', 'MAPK1', 'BAX', 'HRAS', 'ACACA', 'PTK2']",0.9996837755714765,0,0,6
154,Ebstein-Barr virus LMP1 signaling WP262,0.6144475518154052,0.9956645870783547,0.48492022106524824,"['TRADD', 'MAPK1']",0.9996837755714765,0,0,2
155,Eicosanoid Synthesis WP167,0.6144475518154052,0.9956645870783547,0.48492022106524824,"['ALOX5', 'ALOX5AP']",0.9996837755714765,0,0,2
156,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.6144475518154052,0.9956645870783547,0.48492022106524824,"['RPS6', 'MAPK1']",0.9996837755714765,0,0,2
157,Circadian rhythm related genes WP3594,0.6178809880404897,0.9467868355605182,0.45583943697832846,"['KDM5A', 'AHCY', 'KCNH7', 'CAVIN3', 'BTBD9', 'CIART', 'HCRTR1', 'STAR', 'CRH', 'AVP', 'DRD1', 'BTRC', 'RPS27A', 'UBA52']",0.9996837755714765,0,0,14
158,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.6201032428026301,0.941635255433475,0.44997857486698406,"['APEX1', 'RPS6', 'MAPK1', 'BRAF', 'HRAS']",0.9996837755714765,0,0,5
159,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.6222125148518072,0.9379071893930735,0.44501218265426384,"['POMC', 'RPS6KA6', 'RPS6', 'DIO2', 'MAPK1', 'FRS2', 'HRAS']",0.9996837755714765,0,0,7
160,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.6481870035615721,0.9291882556131261,0.40287376290763166,"['GRB10', 'HRAS']",0.9996837755714765,0,0,2
161,Regulation of Microtubule Cytoskeleton WP2038,0.6505322738170009,0.9088888888888889,0.390789837055669,"['TRIO', 'PARD6A', 'F2RL2']",0.9996837755714765,0,0,3
162,Biomarkers for pyrimidine metabolism disorders WP4584,0.6580081259662818,0.9956677937447168,0.41672480530619466,['NT5C'],0.9996837755714765,0,0,1
163,Cancer immunotherapy by CTLA4 blockade WP4582,0.6580081259662818,0.9956677937447168,0.41672480530619466,['HLA-DRB1'],0.9996837755714765,0,0,1
164,IL-9 signaling pathway WP22,0.6580081259662818,0.9956677937447168,0.41672480530619466,['MAPK1'],0.9996837755714765,0,0,1
165,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.6580081259662818,0.9956677937447168,0.41672480530619466,['BAX'],0.9996837755714765,0,0,1
166,Osteoclast Signaling WP12,0.6580081259662818,0.9956677937447168,0.41672480530619466,['TNFRSF11B'],0.9996837755714765,0,0,1
167,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.6580081259662818,0.9956677937447168,0.41672480530619466,['DLL3'],0.9996837755714765,0,0,1
168,Prolactin Signaling Pathway WP2037,0.6685817123961053,0.8892574515471734,0.35801207760985254,"['ZAP70', 'RPS6', 'MAPK1', 'PPIB', 'HRAS', 'PTK2']",0.9996837755714765,0,0,6
169,Interleukin-11 Signaling Pathway WP2332,0.6762688323226318,0.8709259259259259,0.3406753923525112,"['RPS6', 'MAPK1', 'HRAS']",0.9996837755714765,0,0,3
170,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.6762688323226318,0.8709259259259259,0.3406753923525112,"['STAR', 'MAPK1', 'HRAS']",0.9996837755714765,0,0,3
171,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.6781003555391532,0.8708302446256486,0.33828270374373404,"['BEX3', 'MAPK1', 'RNF7', 'PTK2']",0.9996837755714765,0,0,4
172,Netrin-UNC5B signaling pathway WP4747,0.6781003555391532,0.8708302446256486,0.33828270374373404,"['ARHGEF12', 'DAPK1', 'MAPK1', 'PTK2']",0.9996837755714765,0,0,4
173,Angiogenesis WP1539,0.6795366651389785,0.8710214655810511,0.33651399361673384,"['MAPK1', 'PTK2']",0.9996837755714765,0,0,2
174,Estrogen signaling pathway WP712,0.6795366651389785,0.8710214655810511,0.33651399361673384,"['MAPK1', 'BRAF']",0.9996837755714765,0,0,2
175,Unfolded protein response WP4925,0.6795366651389785,0.8710214655810511,0.33651399361673384,"['XBP1', 'DDIT3']",0.9996837755714765,0,0,2
176,Endometrial cancer WP4155,0.6819056128727878,0.8707344213649851,0.33337288811168725,"['GADD45A', 'MAPK1', 'BAX', 'BRAF', 'HRAS']",0.9996837755714765,0,0,5
177,Pancreatic adenocarcinoma pathway WP4263,0.6916290259491238,0.8705423476968797,0.32097380100884887,"['RALB', 'GADD45A', 'RAC3', 'MAPK1', 'BAX', 'BRAF', 'PAK4']",0.9996837755714765,0,0,7
178,Vitamin D Receptor Pathway WP2877,0.69273670195819,0.8887619591603598,0.3262692180399372,"['LRRC25', 'COLEC11', 'CRACR2A', 'GADD45A', 'TNFSF4', 'ALOX5', 'S100A6', 'TNFAIP3', 'TNFRSF11B', 'CD14', 'HLA-DRB1', 'NOX1']",0.9996837755714765,0,0,12
179,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.6993323408196279,0.8443515960194982,0.30196478404977845,"['PSMC5', 'PSMD7', 'PSMC1', 'STUB1']",0.9996837755714765,0,0,4
180,Synaptic Vesicle Pathway WP2267,0.6993323408196279,0.8443515960194982,0.30196478404977845,"['SLC32A1', 'SLC17A6', 'PARK7', 'STX2']",0.9996837755714765,0,0,4
181,DNA Replication WP466,0.700575664399348,0.836,0.29749302790505644,"['POLD4', 'RFC2', 'UBA52']",0.9996837755714765,0,0,3
182,Neural Crest Cell Migration during Development WP4564,0.700575664399348,0.836,0.29749302790505644,"['TRIO', 'F2RL2', 'PAK4']",0.9996837755714765,0,0,3
183,Wnt Signaling Pathway WP363,0.700575664399348,0.836,0.29749302790505644,"['RYK', 'MAPK1', 'CSNK1G1']",0.9996837755714765,0,0,3
184,Cholesterol Biosynthesis Pathway WP197,0.7009513581991546,0.8711168639053254,0.3095224421481983,['PMVK'],0.9996837755714765,0,0,1
185,Cysteine and methionine catabolism WP4504,0.7009513581991546,0.8711168639053254,0.3095224421481983,['AHCY'],0.9996837755714765,0,0,1
186,Genes targeted by miRNAs in adipocytes WP1992,0.7009513581991546,0.8711168639053254,0.3095224421481983,['TMSB4X'],0.9996837755714765,0,0,1
187,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.7009513581991546,0.8711168639053254,0.3095224421481983,['MAPK1'],0.9996837755714765,0,0,1
188,Nanoparticle triggered autophagic cell death WP2509,0.7009513581991546,0.8711168639053254,0.3095224421481983,['MAP1LC3A'],0.9996837755714765,0,0,1
189,Nephrogenesis WP5052,0.7009513581991546,0.8711168639053254,0.3095224421481983,['PAX2'],0.9996837755714765,0,0,1
190,Osteoblast Signaling WP322,0.7009513581991546,0.8711168639053254,0.3095224421481983,['TNFRSF11B'],0.9996837755714765,0,0,1
191,Osteopontin Signaling WP1434,0.7009513581991546,0.8711168639053254,0.3095224421481983,['MAPK1'],0.9996837755714765,0,0,1
192,Pyrimidine metabolism and related diseases WP4225,0.7009513581991546,0.8711168639053254,0.3095224421481983,['NT5C'],0.9996837755714765,0,0,1
193,Tamoxifen metabolism WP691,0.7009513581991546,0.8711168639053254,0.3095224421481983,['CYP2C8'],0.9996837755714765,0,0,1
194,Ethanol effects on histone modifications WP3996,0.7085646269083572,0.8196978273174554,0.2823973834165555,"['AHCY', 'HDAC9']",0.9996837755714765,0,0,2
195,Fluoropyrimidine Activity WP1601,0.7085646269083572,0.8196978273174554,0.2823973834165555,"['TDG', 'TK1']",0.9996837755714765,0,0,2
196,Imatinib and Chronic Myeloid Leukemia WP3640,0.7085646269083572,0.8196978273174554,0.2823973834165555,"['GADD45A', 'SKP2']",0.9996837755714765,0,0,2
197,Inflammatory Response Pathway WP453,0.7085646269083572,0.8196978273174554,0.2823973834165555,"['LAMA5', 'ZAP70']",0.9996837755714765,0,0,2
198,Sphingolipid pathway WP1422,0.7085646269083572,0.8196978273174554,0.2823973834165555,"['CERS6', 'GBA2']",0.9996837755714765,0,0,2
199,Monoamine GPCRs WP58,0.7234664857386934,0.8037606837606838,0.26017818241831997,"['CHRM3', 'CHRM5', 'DRD1']",0.9996837755714765,0,0,3
200,Cell migration and invasion through p75NTR WP4561,0.7353595146530225,0.7740768155275928,0.23794793392944683,"['NTRK2', 'TRIO']",0.9996837755714765,0,0,2
201,GABA receptor Signaling WP4159,0.7353595146530225,0.7740768155275928,0.23794793392944683,"['SLC32A1', 'GABRA4']",0.9996837755714765,0,0,2
202,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.7353595146530225,0.7740768155275928,0.23794793392944683,"['SUPT4H1', 'HDAC9']",0.9996837755714765,0,0,2
203,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.7353595146530225,0.7740768155275928,0.23794793392944683,"['TNFRSF11B', 'PPIB']",0.9996837755714765,0,0,2
204,Alzheimer's disease WP2059,0.7365673083201139,0.809726726933959,0.24757771832021377,"['PSENEN', 'ATP5MD', 'MAPK1', 'CYCS', 'HSD17B10']",0.9996837755714765,0,0,5
205,Androgen receptor signaling pathway WP138,0.7366087031672504,0.819162408838814,0.25041668664052413,"['SUMO1', 'BAG1', 'DSTN', 'STUB1', 'PARK7', 'PTK2']",0.9996837755714765,0,0,6
206,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.7385057533439262,0.7742439184746877,0.23469376124605,['MAPK1'],0.9996837755714765,0,0,1
207,Computational Model of Aerobic Glycolysis WP4629,0.7385057533439262,0.7742439184746877,0.23469376124605,['ALDOA'],0.9996837755714765,0,0,1
208,Cori Cycle WP1946,0.7385057533439262,0.7742439184746877,0.23469376124605,['ALDOA'],0.9996837755714765,0,0,1
209,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.7385057533439262,0.7742439184746877,0.23469376124605,['BAX'],0.9996837755714765,0,0,1
210,Immune response to tuberculosis WP4197,0.7385057533439262,0.7742439184746877,0.23469376124605,['PSMB8'],0.9996837755714765,0,0,1
211,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.7385057533439262,0.7742439184746877,0.23469376124605,['MAPK1'],0.9996837755714765,0,0,1
212,Nucleotide metabolism WP404,0.7385057533439262,0.7742439184746877,0.23469376124605,['NME2'],0.9996837755714765,0,0,1
213,Pre-implantation embryo WP3527,0.7449664699197002,0.7739094650205761,0.22785138201568975,"['DDIT3', 'CELF3', 'FOSB']",0.9996837755714765,0,0,3
214,Common Pathways Underlying Drug Addiction WP2636,0.7600242716223838,0.733258015505084,0.20120959965354113,"['MAPK1', 'DRD1']",0.9996837755714765,0,0,2
215,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.7600242716223838,0.733258015505084,0.20120959965354113,"['NTRK2', 'GABRA4']",0.9996837755714765,0,0,2
216,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.7651101162276802,0.7461904761904762,0.19978168973940422,"['ITGB2', 'MAP4K3', 'PAK4']",0.9996837755714765,0,0,3
217,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.7651101162276802,0.7461904761904762,0.19978168973940422,"['TNFSF4', 'RPS6', 'MAPK1']",0.9996837755714765,0,0,3
218,Galanin receptor pathway WP4970,0.7713471044397411,0.6967455621301775,0.18088685772588195,['POMC'],0.9996837755714765,0,0,1
219,Glutathione metabolism WP100,0.7713471044397411,0.6967455621301775,0.18088685772588195,['GPX4'],0.9996837755714765,0,0,1
220,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.7713471044397411,0.6967455621301775,0.18088685772588195,['GRM7'],0.9996837755714765,0,0,1
221,ID signaling pathway WP53,0.7713471044397411,0.6967455621301775,0.18088685772588195,['PAX2'],0.9996837755714765,0,0,1
222,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.7713471044397411,0.6967455621301775,0.18088685772588195,['NRG3'],0.9996837755714765,0,0,1
223,miR-509-3p alteration of YAP1/ECM axis WP3967,0.7713471044397411,0.6967455621301775,0.18088685772588195,['GPC6'],0.9996837755714765,0,0,1
224,MTHFR deficiency WP4288,0.7713471044397411,0.6967455621301775,0.18088685772588195,['CYCS'],0.9996837755714765,0,0,1
225,NOTCH1 regulation of endothelial cell calcification WP3413,0.7713471044397411,0.6967455621301775,0.18088685772588195,['DLL3'],0.9996837755714765,0,0,1
226,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.7713471044397411,0.6967455621301775,0.18088685772588195,['ANAPC11'],0.9996837755714765,0,0,1
227,SARS coronavirus and innate immunity WP4912,0.7713471044397411,0.6967455621301775,0.18088685772588195,['IKBKE'],0.9996837755714765,0,0,1
228,EGF/EGFR signaling pathway WP437,0.7818179956975558,0.8140913847227067,0.20037500521062887,"['NDUFA13', 'ATXN2', 'RALB', 'GRB10', 'MAPK1', 'FOSB', 'BRAF', 'NEDD8', 'HRAS', 'PTK2', 'CRKL']",0.9996837755714765,0,0,11
229,Heart Development WP1591,0.7826711758610561,0.6965210954848261,0.1706773578821594,"['VEGFB', 'MAPK1']",0.9996837755714765,0,0,2
230,T-cell receptor (TCR) signaling pathway WP69,0.798296661845045,0.7404981375086811,0.1668157134240598,"['ZAP70', 'CD4', 'MAPK1', 'HRAS', 'CRKL']",0.9996837755714765,0,0,5
231,Apoptosis Modulation by HSP70 WP384,0.8000665107514665,0.6333378160301237,0.14127259692164626,['CYCS'],0.9996837755714765,0,0,1
232,Cells and molecules involved in local acute inflammatory response  WP4493,0.8000665107514665,0.6333378160301237,0.14127259692164626,['ITGB2'],0.9996837755714765,0,0,1
233,Development and heterogeneity of the ILC family WP3893,0.8000665107514665,0.6333378160301237,0.14127259692164626,['IL18'],0.9996837755714765,0,0,1
234,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.8000665107514665,0.6333378160301237,0.14127259692164626,['HIST1H3E'],0.9996837755714765,0,0,1
235,Hypertrophy Model WP516,0.8000665107514665,0.6333378160301237,0.14127259692164626,['IL18'],0.9996837755714765,0,0,1
236,PPAR-alpha pathway WP2878,0.8000665107514665,0.6333378160301237,0.14127259692164626,['DBI'],0.9996837755714765,0,0,1
237,Selective expression of chemokine receptors during T-cell polarization WP4494,0.8000665107514665,0.6333378160301237,0.14127259692164626,['CD4'],0.9996837755714765,0,0,1
238,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.8000665107514665,0.6333378160301237,0.14127259692164626,['EXOC6'],0.9996837755714765,0,0,1
239,Transcriptional cascade regulating adipogenesis WP4211,0.8000665107514665,0.6333378160301237,0.14127259692164626,['DDIT3'],0.9996837755714765,0,0,1
240,Exercise-induced Circadian Regulation WP410,0.8015018608502847,0.6962962962962963,0.15406807860151095,"['SUMO1', 'GSTP1', 'UCP3']",0.9996837755714765,0,0,3
241,TGF-beta Signaling Pathway WP366,0.8021847134896072,0.7730689797604295,0.17039706721698264,"['PARD6A', 'CITED1', 'SUMO1', 'NEDD4L', 'MAPK1', 'FOSB', 'BTRC', 'PTK2']",0.9996837755714765,0,0,8
242,Endothelin Pathways WP2197,0.8034178808484091,0.6632829297522118,0.1451795672022973,"['RIIAD1', 'MAPK1']",0.9996837755714765,0,0,2
243,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.8034178808484091,0.6632829297522118,0.1451795672022973,"['DDIT3', 'MAPK1']",0.9996837755714765,0,0,2
244,MECP2 and Associated Rett Syndrome WP3584,0.8055388364992838,0.7139951721122959,0.15439707444906203,"['SST', 'RPS6', 'TET3', 'NF1']",0.9996837755714765,0,0,4
245,Hippo-Merlin Signaling Dysregulation WP4541,0.813156504267603,0.7623975148953506,0.15768796324510564,"['NTRK2', 'ITGB2', 'CDH13', 'ITGAE', 'HRAS', 'CDH8', 'PTK2', 'PAK4']",0.9996837755714765,0,0,8
246,Interferon type I signaling pathways WP585,0.8178496149226617,0.673763440860215,0.1354781994202215,"['ZAP70', 'RPS6', 'CRKL']",0.9996837755714765,0,0,3
247,B Cell Receptor Signaling Pathway WP23,0.8189375821514521,0.7324659086468956,0.14630816838720176,"['CD81', 'MAPK1', 'BRAF', 'PIK3AP1', 'HRAS', 'CRKL']",0.9996837755714765,0,0,6
248,Pathways in clear cell renal cell carcinoma WP4018,0.8189375821514521,0.7324659086468956,0.14630816838720176,"['SETD2', 'ME1', 'GRB10', 'CDH13', 'ALDOA', 'ACACA']",0.9996837755714765,0,0,6
249,Senescence and Autophagy in Cancer WP615,0.8189375821514521,0.7324659086468956,0.14630816838720176,"['GABARAPL2', 'MAP1LC3A', 'MAPK1', 'BRAF', 'HRAS', 'GABARAP']",0.9996837755714765,0,0,6
250,Aryl Hydrocarbon Receptor Pathway WP2873,0.8223843017403352,0.6330664154498351,0.12379453766474768,"['AIP', 'BAX']",0.9996837755714765,0,0,2
251,PDGF Pathway WP2526,0.8223843017403352,0.6330664154498351,0.12379453766474768,"['MAPK1', 'HRAS']",0.9996837755714765,0,0,2
252,TYROBP causal network in microglia WP3945,0.8245875186823566,0.7101223278628959,0.13696271009206082,"['CD4', 'NCF2', 'ITGB2', 'IL18', 'SLC1A5']",0.9996837755714765,0,0,5
253,MAPK pathway in congenital thyroid cancer WP4928,0.8251809855021182,0.5804980276134122,0.11154417066869957,['BRAF'],0.9996837755714765,0,0,1
254,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.8251809855021182,0.5804980276134122,0.11154417066869957,['SCO2'],0.9996837755714765,0,0,1
255,Signal Transduction of S1P Receptor WP26,0.8251809855021182,0.5804980276134122,0.11154417066869957,['MAPK1'],0.9996837755714765,0,0,1
256,Sphingolipid Metabolism (general overview) WP4725,0.8251809855021182,0.5804980276134122,0.11154417066869957,['CERS6'],0.9996837755714765,0,0,1
257,Sphingolipid Metabolism (integrated pathway) WP4726,0.8251809855021182,0.5804980276134122,0.11154417066869957,['CERS6'],0.9996837755714765,0,0,1
258,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.8251809855021182,0.5804980276134122,0.11154417066869957,['IKBKE'],0.9996837755714765,0,0,1
259,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.8251809855021182,0.5804980276134122,0.11154417066869957,['ZAP70'],0.9996837755714765,0,0,1
260,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.8251809855021182,0.5804980276134122,0.11154417066869957,['MAPK1'],0.9996837755714765,0,0,1
261,Transcription co-factors SKI and SKIL protein partners WP4533,0.8251809855021182,0.5804980276134122,0.11154417066869957,['NF1'],0.9996837755714765,0,0,1
262,IL-3 signaling pathway WP286,0.8330376128476985,0.6526388888888889,0.11922177777626249,"['MAPK1', 'HRAS', 'CRKL']",0.9996837755714765,0,0,3
263,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.8333457055273421,0.6790214974054856,0.12379017539552298,"['MAPK1', 'BAX', 'HRAS', 'PTK2']",0.9996837755714765,0,0,4
264,Notch Signaling WP268,0.83969019740182,0.6054774241302738,0.10579038863954306,"['DTX3', 'DLL3']",0.9996837755714765,0,0,2
265,NRF2 pathway WP2884,0.8432781784014344,0.7320680884367051,0.12478714711947168,"['SERPINA1', 'FTH1', 'GSTP1', 'ME1', 'TXN', 'SLC6A20', 'SLC5A3', 'FTL']",0.9996837755714765,0,0,8
266,Cardiac Hypertrophic Response WP2795,0.8471227902160329,0.6327946127946128,0.10498671634012458,"['MAPK1', 'IKBKE', 'HDAC9']",0.9996837755714765,0,0,3
267,Blood Clotting Cascade WP272,0.8471427350566256,0.5357874374146564,0.08887967779220911,['F11'],0.9996837755714765,0,0,1
268,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.8471427350566256,0.5357874374146564,0.08887967779220911,['GSTP1'],0.9996837755714765,0,0,1
269,Physiological and pathological hypertrophy of the heart WP1528,0.8471427350566256,0.5357874374146564,0.08887967779220911,['MAPK1'],0.9996837755714765,0,0,1
270,Integrated breast cancer pathway WP1984,0.8524190569015921,0.7224834644908994,0.11536400823356018,"['GADD45A', 'TRADD', 'NF1', 'MAPK1', 'BAX', 'BRAF', 'PHB', 'FAU']",0.9996837755714765,0,0,8
271,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.8554533229043978,0.580187515420676,0.09058104963916333,"['ITGB2', 'CD14']",0.9996837755714765,0,0,2
272,Toll-like Receptor Signaling related to MyD88 WP3858,0.8554533229043978,0.580187515420676,0.09058104963916333,"['MAPK1', 'IKBKE']",0.9996837755714765,0,0,2
273,16p11.2 proximal deletion syndrome WP4949,0.8577523902066024,0.6473011877876808,0.09932177168567659,"['SPN', 'TMEM219', 'ALDOA', 'SEZ6L2']",0.9996837755714765,0,0,4
274,Breast cancer pathway WP4262,0.8581495609506927,0.7275747508305648,0.11130211623841028,"['FGF17', 'SHC3', 'GADD45A', 'FZD9', 'MAPK1', 'BAX', 'BRAF', 'HRAS', 'DLL3']",0.9996837755714765,0,0,9
275,RANKL/RANK signaling pathway WP2018,0.8601630959630249,0.6141176470588235,0.09250654396553962,"['MAPK1', 'TNFRSF11B', 'PTK2']",0.9996837755714765,0,0,3
276,Focal Adhesion WP306,0.860217035880082,0.7590806471842468,0.11429519378325062,"['LAMA5', 'SHC3', 'VEGFB', 'BRAF', 'MYL12A', 'PTK2', 'ARHGAP35', 'CRKL', 'COL4A1', 'RAC3', 'MAPK1', 'HRAS', 'PAK4']",0.9996837755714765,0,0,13
277,Apoptosis Modulation and Signaling WP1772,0.8615036796550615,0.6841432691956625,0.10198930902591628,"['ENDOG', 'TRADD', 'CYCS', 'BAX', 'TNFRSF11B', 'TNFRSF10D']",0.9996837755714765,0,0,6
278,Small cell lung cancer WP4658,0.8615036796550615,0.6841432691956625,0.10198930902591628,"['LAMA5', 'COL4A1', 'GADD45A', 'CYCS', 'BAX', 'PTK2']",0.9996837755714765,0,0,6
279,EPO Receptor Signaling WP581,0.8663472774462179,0.4974640743871513,0.07137089097189851,['MAPK1'],0.9996837755714765,0,0,1
280,FOXA2 pathway WP5066,0.8663472774462179,0.4974640743871513,0.07137089097189851,['ACACA'],0.9996837755714765,0,0,1
281,GDNF/RET signaling axis WP4830,0.8663472774462179,0.4974640743871513,0.07137089097189851,['PAX2'],0.9996837755714765,0,0,1
282,Hippo-Yap signaling pathway WP4537,0.8663472774462179,0.4974640743871513,0.07137089097189851,['MAP4K3'],0.9996837755714765,0,0,1
283,IL-7 signaling pathway WP205,0.8663472774462179,0.4974640743871513,0.07137089097189851,['MAPK1'],0.9996837755714765,0,0,1
284,miRNA regulation of p53 pathway in prostate cancer WP3982,0.8663472774462179,0.4974640743871513,0.07137089097189851,['BAX'],0.9996837755714765,0,0,1
285,miRNA targets in ECM and membrane receptors WP2911,0.8663472774462179,0.4974640743871513,0.07137089097189851,['COL4A1'],0.9996837755714765,0,0,1
286,One-carbon metabolism WP241,0.8663472774462179,0.4974640743871513,0.07137089097189851,['AHCY'],0.9996837755714765,0,0,1
287,Proteoglycan biosynthesis WP4784,0.8663472774462179,0.4974640743871513,0.07137089097189851,['EXT2'],0.9996837755714765,0,0,1
288,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.8663472774462179,0.4974640743871513,0.07137089097189851,['BAX'],0.9996837755714765,0,0,1
289,Trans-sulfuration and one-carbon metabolism WP2525,0.8663472774462179,0.4974640743871513,0.07137089097189851,['AHCY'],0.9996837755714765,0,0,1
290,DNA IR-double strand breaks and cellular response via ATM WP3959,0.8697880472604502,0.556920799407846,0.07769363757952012,"['DCLRE1C', 'BAX']",0.9996837755714765,0,0,2
291,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.8697880472604502,0.556920799407846,0.07769363757952012,"['MAPK1', 'HRAS']",0.9996837755714765,0,0,2
292,Fas ligand pathway and stress induction of heat shock proteins WP314,0.8697880472604502,0.556920799407846,0.07769363757952012,"['ARHGDIB', 'CYCS']",0.9996837755714765,0,0,2
293,Oxidative Damage WP3941,0.8697880472604502,0.556920799407846,0.07769363757952012,"['GADD45A', 'CYCS']",0.9996837755714765,0,0,2
294,MAPK Signaling Pathway WP382,0.8722722656176217,0.7663064503649447,0.10471859077507878,"['NTRK2', 'GADD45A', 'RRAS2', 'BRAF', 'CRKL', 'FGF17', 'CACNA1I', 'DDIT3', 'NF1', 'RAC3', 'RAPGEF2', 'MAPK1', 'CD14', 'PTPN7', 'HRAS', 'MAP4K3']",0.9996837755714765,0,0,16
295,Thermogenesis WP4321,0.8782820404220194,0.6440268161336411,0.0835866345088083,"['RPS6KA6', 'RPS6', 'FRS2', 'CPT1B', 'HRAS']",0.9996837755714765,0,0,5
296,IL-5 signaling pathway WP127,0.8828043495558183,0.5354438307806183,0.0667439717735033,"['RPS6', 'MAPK1']",0.9996837755714765,0,0,2
297,16p11.2 distal deletion syndrome WP4950,0.883140543927215,0.46425049309664695,0.05769283804555737,['CD81'],0.9996837755714765,0,0,1
298,Cannabinoid receptor signaling WP3869,0.883140543927215,0.46425049309664695,0.05769283804555737,['MAPK1'],0.9996837755714765,0,0,1
299,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.883140543927215,0.46425049309664695,0.05769283804555737,['MAPK1'],0.9996837755714765,0,0,1
300,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.883140543927215,0.46425049309664695,0.05769283804555737,['MAPK1'],0.9996837755714765,0,0,1
301,Purinergic signaling WP4900,0.883140543927215,0.46425049309664695,0.05769283804555737,['P2RX6'],0.9996837755714765,0,0,1
302,Statin inhibition of cholesterol production WP430,0.883140543927215,0.46425049309664695,0.05769283804555737,['APOC1'],0.9996837755714765,0,0,1
303,Striated Muscle Contraction Pathway WP383,0.883140543927215,0.46425049309664695,0.05769283804555737,['TPM2'],0.9996837755714765,0,0,1
304,Oncostatin M Signaling Pathway WP2374,0.883341430345116,0.5798765432098766,0.07192990571430463,"['RPS6', 'MAPK1', 'HRAS']",0.9996837755714765,0,0,3
305,Chemokine signaling pathway WP3929,0.8847812224119193,0.6865115425214557,0.08403922181407097,"['GNG10', 'GNG3', 'SHC3', 'MAPK1', 'BRAF', 'HRAS', 'PTK2', 'CRKL']",0.9996837755714765,0,0,8
306,Regulatory circuits of the STAT3 signaling pathway WP4538,0.8886128909813263,0.6048925129725723,0.07143392328960788,"['PTPRD', 'CSF3R', 'MAPK1', 'F2RL2']",0.9996837755714765,0,0,4
307,7-oxo-C and 7beta-HC pathways WP5064,0.8978250920248395,0.43518860946745563,0.046904630364682516,['HSD11B2'],0.9996837755714765,0,0,1
308,Fatty acid beta-oxidation WP143,0.8978250920248395,0.43518860946745563,0.046904630364682516,['CPT1B'],0.9996837755714765,0,0,1
309,PDGFR-beta pathway WP3972,0.8978250920248395,0.43518860946745563,0.046904630364682516,['HRAS'],0.9996837755714765,0,0,1
310,TLR4 Signaling and Tolerance WP3851,0.8978250920248395,0.43518860946745563,0.046904630364682516,['IKBKE'],0.9996837755714765,0,0,1
311,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.8986151801457152,0.6698257714874367,0.07160463579012291,"['NTRK2', 'SHC3', 'NCF2', 'RPS6', 'MAPK1', 'FRS2', 'EIF2S2', 'HRAS']",0.9996837755714765,0,0,8
312,Prader-Willi and Angelman Syndrome WP3998,0.9030301509807468,0.5492397660818713,0.056022091627582225,"['POMC', 'FEZ1', 'GNRH1']",0.9996837755714765,0,0,3
313,Proximal tubule transport WP4917,0.9030301509807468,0.5492397660818713,0.056022091627582225,"['SLC7A9', 'SLC6A20', 'ATP6V1F']",0.9996837755714765,0,0,3
314,Metabolic reprogramming in colon cancer WP4290,0.905295702856305,0.4970921010891403,0.049457505119396,"['IDH2', 'SLC1A5']",0.9996837755714765,0,0,2
315,Canonical and non-canonical Notch signaling WP3845,0.9106655400114648,0.40954577097111033,0.03832512293238567,['DLL3'],0.9996837755714765,0,0,1
316,IL1 and megakaryocytes in obesity WP2865,0.9106655400114648,0.40954577097111033,0.03832512293238567,['IL18'],0.9996837755714765,0,0,1
317,RAS and bradykinin pathways in COVID-19 WP4969,0.9106655400114648,0.40954577097111033,0.03832512293238567,['MAPK1'],0.9996837755714765,0,0,1
318,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.9149636399312825,0.47989994639985706,0.042649165233853294,"['DBI', 'ACACA']",0.9996837755714765,0,0,2
319,Vitamin A and carotenoid metabolism WP716,0.9149636399312825,0.47989994639985706,0.042649165233853294,"['RBP7', 'MAPK1']",0.9996837755714765,0,0,2
320,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.9218933213856781,0.38675213675213677,0.0314529136211074,['ALOX5'],0.9996837755714765,0,0,1
321,Lipid Metabolism Pathway WP3965,0.9218933213856781,0.38675213675213677,0.0314529136211074,['ACACA'],0.9996837755714765,0,0,1
322,Oxidative Stress WP408,0.9218933213856781,0.38675213675213677,0.0314529136211074,['NOX1'],0.9996837755714765,0,0,1
323,Pregnane X receptor pathway WP2876,0.9218933213856781,0.38675213675213677,0.0314529136211074,['PSMC5'],0.9996837755714765,0,0,1
324,Type II interferon signaling (IFNG) WP619,0.9218933213856781,0.38675213675213677,0.0314529136211074,['HLA-B'],0.9996837755714765,0,0,1
325,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.9236985584346493,0.463853935356526,0.03681585307945928,"['RPS6', 'MAPK1']",0.9996837755714765,0,0,2
326,Allograft Rejection WP2328,0.9269667916913898,0.5088888888888888,0.03859288018227681,"['HLA-B', 'HLA-DOA', 'HLA-DRB1']",0.9996837755714765,0,0,3
327,Glucocorticoid Receptor Pathway WP2880,0.9269667916913898,0.5088888888888888,0.03859288018227681,"['GPR153', 'ALOX5AP', 'TNFAIP3']",0.9996837755714765,0,0,3
328,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.9269667916913898,0.5088888888888888,0.03859288018227681,"['IFI27L2', 'MAPK1', 'HRAS']",0.9996837755714765,0,0,3
329,Fragile X Syndrome  WP4549,0.9295161172337836,0.5696964537627086,0.04163975886691603,"['NTRK2', 'DLG4', 'NF1', 'MAPK1', 'BRAF']",0.9996837755714765,0,0,5
330,Phosphodiesterases in neuronal function WP4222,0.931582182616675,0.44884315083211956,0.031809903124098024,"['PDE6G', 'DRD1']",0.9996837755714765,0,0,2
331,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.931582182616675,0.44884315083211956,0.031809903124098024,"['ZAP70', 'CD4']",0.9996837755714765,0,0,2
332,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.9317108437130086,0.3663578324509499,0.025913502821077822,['HRAS'],0.9996837755714765,0,0,1
333,Phosphoinositides metabolism WP4971,0.9317108437130086,0.3663578324509499,0.025913502821077822,['SBF2'],0.9996837755714765,0,0,1
334,Resistin as a regulator of inflammation WP4481,0.9317108437130086,0.3663578324509499,0.025913502821077822,['MAPK1'],0.9996837755714765,0,0,1
335,DNA damage response WP707,0.9336539849289515,0.4967195767195767,0.034099488595149906,"['GADD45A', 'CYCS', 'BAX']",0.9996837755714765,0,0,3
336,ESC Pluripotency Pathways WP3931,0.9350009708882482,0.5604479754953575,0.0376664257418345,"['FGF17', 'FZD9', 'MAPK1', 'BRAF', 'HRAS']",0.9996837755714765,0,0,5
337,Glioblastoma signaling pathways WP2261,0.9388492162289257,0.5246094241716436,0.033103060188318906,"['NF1', 'MAPK1', 'BRAF', 'HRAS']",0.9996837755714765,0,0,4
338,miRNA regulation of DNA damage response WP1530,0.9397723784598366,0.48511627906976745,0.030134251028557154,"['GADD45A', 'CYCS', 'BAX']",0.9996837755714765,0,0,3
339,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.9402951265323385,0.34800295857988167,0.02142358016685615,['SBF2'],0.9996837755714765,0,0,1
340,Monoamine Transport WP727,0.9402951265323385,0.34800295857988167,0.02142358016685615,['TNFRSF11B'],0.9996837755714765,0,0,1
341,Wnt signaling in kidney disease WP4150,0.9402951265323385,0.34800295857988167,0.02142358016685615,['FZD9'],0.9996837755714765,0,0,1
342,Insulin Signaling WP481,0.944752854806026,0.6037174721189591,0.03431042005883938,"['RPS6KA6', 'XBP1', 'SHC3', 'RHOJ', 'GRB10', 'MAPK1', 'HRAS', 'MAP4K3']",0.9996837755714765,0,0,8
343,Pathogenic Escherichia coli infection WP2272,0.9450936032059164,0.42155081533319877,0.0238055248267417,"['ARPC1B', 'CD14']",0.9996837755714765,0,0,2
344,Prostaglandin Synthesis and Regulation WP98,0.9450936032059164,0.42155081533319877,0.0238055248267417,"['HSD11B2', 'S100A6']",0.9996837755714765,0,0,2
345,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9467581012133894,0.5631734184072714,0.03081214998161822,"['RPS6KA6', 'SHC3', 'DIO2', 'MAPK1', 'HRAS', 'MAP4K3']",0.9996837755714765,0,0,6
346,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.9478009839922072,0.33139616793462945,0.017766390900962825,['IKBKE'],0.9996837755714765,0,0,1
347,miRNA regulation of prostate cancer signaling pathways WP3981,0.9478009839922072,0.33139616793462945,0.017766390900962825,['MAPK1'],0.9996837755714765,0,0,1
348,White fat cell differentiation WP4149,0.9478009839922072,0.33139616793462945,0.017766390900962825,['DDIT3'],0.9996837755714765,0,0,1
349,Genes related to primary cilium development (based on CRISPR) WP4536,0.9504709594042796,0.4634567901234568,0.023542525310127762,"['DYNLT1', 'TTC21B', 'DYNLL1']",0.9996837755714765,0,0,3
350,Notch Signaling Pathway Netpath WP61,0.9508565597699782,0.40910872120869074,0.0206158307180794,"['PSENEN', 'DLL3']",0.9996837755714765,0,0,2
351,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9529066543834954,0.5717594615855257,0.027580721220145495,"['COL4A1', 'CTDSP1', 'FZD9', 'MAPK1', 'WNT9A', 'HRAS', 'DLL3']",0.9996837755714765,0,0,7
352,ATM Signaling Pathway WP2516,0.9543638082225405,0.31629908552985475,0.014774434629421362,['GADD45A'],0.9996837755714765,0,0,1
353,IL17 signaling pathway WP2112,0.9543638082225405,0.31629908552985475,0.014774434629421362,['MAPK1'],0.9996837755714765,0,0,1
354,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.9543638082225405,0.31629908552985475,0.014774434629421362,['RAB13'],0.9996837755714765,0,0,1
355,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.9543638082225405,0.31629908552985475,0.014774434629421362,['STAR'],0.9996837755714765,0,0,1
356,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.9543638082225405,0.31629908552985475,0.014774434629421362,['IKBKE'],0.9996837755714765,0,0,1
357,Folate Metabolism WP176,0.9560390113798826,0.39737760389129745,0.017864730044545127,"['AHCY', 'GPX4']",0.9996837755714765,0,0,2
358,Ebola Virus Pathway on Host WP4217,0.9570820997410378,0.5183466938305505,0.022737849230977325,"['HLA-B', 'MAPK1', 'HLA-DOA', 'IKBKE', 'HLA-DRB1']",0.9996837755714765,0,0,5
359,Apoptosis WP254,0.9593749283905734,0.4436406619385343,0.01839925240122166,"['TRADD', 'CYCS', 'BAX']",0.9996837755714765,0,0,3
360,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9593749283905734,0.4436406619385343,0.01839925240122166,"['MAPK1', 'IKBKE', 'HDAC9']",0.9996837755714765,0,0,3
361,ATM Signaling Network in Development and Disease  WP3878,0.9601020044207313,0.3025147928994083,0.012317115335812472,['DCLRE1C'],0.9996837755714765,0,0,1
362,G13 Signaling Pathway WP524,0.9601020044207313,0.3025147928994083,0.012317115335812472,['ARHGDIB'],0.9996837755714765,0,0,1
363,Genes controlling nephrogenesis WP4823,0.9601020044207313,0.3025147928994083,0.012317115335812472,['PAX2'],0.9996837755714765,0,0,1
364,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.9601020044207313,0.3025147928994083,0.012317115335812472,['LAMA5'],0.9996837755714765,0,0,1
365,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.9601020044207313,0.3025147928994083,0.012317115335812472,['BAX'],0.9996837755714765,0,0,1
366,Energy Metabolism WP1541,0.9651191207488258,0.28987919132149903,0.010291796620156486,['UCP3'],0.9996837755714765,0,0,1
367,Rett syndrome causing genes WP4312,0.9651191207488258,0.28987919132149903,0.010291796620156486,['BRAF'],0.9996837755714765,0,0,1
368,Tryptophan metabolism WP465,0.9651191207488258,0.28987919132149903,0.010291796620156486,['HSD17B10'],0.9996837755714765,0,0,1
369,Head and Neck Squamous Cell Carcinoma WP4674,0.9667591777348339,0.4254421768707483,0.01438243660588232,"['RPS6', 'CSMD3', 'HRAS']",0.9996837755714765,0,0,3
370,Cardiac Progenitor Differentiation WP2406,0.9695057113470354,0.2782544378698225,0.008617237559932735,['MESP1'],0.9996837755714765,0,0,1
371,Hedgehog Signaling Pathway WP4249,0.9695057113470354,0.2782544378698225,0.008617237559932735,['CSNK1G1'],0.9996837755714765,0,0,1
372,IL-6 signaling pathway WP364,0.9695057113470354,0.2782544378698225,0.008617237559932735,['MAPK1'],0.9996837755714765,0,0,1
373,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.9695057113470354,0.2782544378698225,0.008617237559932735,['MAPK1'],0.9996837755714765,0,0,1
374,Metapathway biotransformation Phase I and II WP702,0.9720034893839096,0.5077951002227171,0.014419291080080242,"['GSTK1', 'CYP2C8', 'GPX4', 'GSTO1', 'GSTP1', 'CHST10']",0.9996837755714765,0,0,6
375,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.9733409657112966,0.2675238962221211,0.007228717970744558,['PMVK'],0.9996837755714765,0,0,1
376,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.9733409657112966,0.2675238962221211,0.007228717970744558,['MAP1LC3A'],0.9996837755714765,0,0,1
377,Integrated Cancer Pathway WP1971,0.9733409657112966,0.2675238962221211,0.007228717970744558,['BAX'],0.9996837755714765,0,0,1
378,Neovascularisation processes WP4331,0.9733409657112966,0.2675238962221211,0.007228717970744558,['MAPK1'],0.9996837755714765,0,0,1
379,One-carbon metabolism and related pathways WP3940,0.9733409657112966,0.2675238962221211,0.007228717970744558,['GPX4'],0.9996837755714765,0,0,1
380,AMP-activated protein kinase (AMPK) signaling WP1403,0.9750072032674714,0.347520355292376,0.00879588616661803,"['CPT1B', 'ACACA']",0.9996837755714765,0,0,2
381,Pathways affected in adenoid cystic carcinoma WP3651,0.9750072032674714,0.347520355292376,0.00879588616661803,"['SETD2', 'HRAS']",0.9996837755714765,0,0,2
382,G Protein Signaling Pathways WP35,0.9755008498523557,0.40076923076923077,0.009940779279626456,"['GNG10', 'GNG3', 'HRAS']",0.9996837755714765,0,0,3
383,Development of ureteric collection system WP5053,0.9796257749118864,0.24836221470836856,0.0051124474202276764,['PAX2'],0.9996837755714765,0,0,1
384,Oxidation by Cytochrome P450 WP43,0.9796257749118864,0.24836221470836856,0.0051124474202276764,['CYP2C8'],0.9996837755714765,0,0,1
385,Toll-like Receptor Signaling Pathway WP75,0.9800627377132506,0.38584362139917694,0.007770385578284945,"['MAPK1', 'CD14', 'IKBKE']",0.9996837755714765,0,0,3
386,Regulation of toll-like receptor signaling pathway WP1449,0.9821034262171826,0.4505472272534587,0.008136276559816606,"['CUEDC2', 'TNFAIP3', 'MAPK1', 'CD14', 'IKBKE']",0.9996837755714765,0,0,5
387,G1 to S cell cycle control WP45,0.982284236244156,0.32317146644174,0.00577654978121154,"['GADD45A', 'MNAT1']",0.9996837755714765,0,0,2
388,Nuclear Receptors Meta-Pathway WP2882,0.9830729276188169,0.5998729878949688,0.010241015307553298,"['SERPINA1', 'GSTP1', 'AIP', 'TNFAIP3', 'DBI', 'TXN', 'SLC6A20', 'SLC5A3', 'PSMC5', 'GPR153', 'FTH1', 'ALOX5AP', 'ME1', 'BAX', 'FTL']",0.9996837755714765,0,0,15
389,Hepatitis B infection WP4666,0.9831015487916567,0.47286900182223124,0.008059039815409792,"['CYCS', 'MAPK1', 'BAX', 'BRAF', 'IKBKE', 'HRAS']",0.9996837755714765,0,0,6
390,DNA damage response (only ATM dependent) WP710,0.9832830948879164,0.4143699589524579,0.0069855356058789436,"['RAC3', 'MAPK1', 'BAX', 'HRAS']",0.9996837755714765,0,0,4
391,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.9844296467729653,0.23175542406311636,0.003636901791745144,['BAX'],0.9996837755714765,0,0,1
392,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.9844296467729653,0.23175542406311636,0.003636901791745144,['TRADD'],0.9996837755714765,0,0,1
393,AGE/RAGE pathway WP2324,0.9859432924220168,0.3087424952709927,0.004370694236175317,"['MAPK1', 'CYCS']",0.9996837755714765,0,0,2
394,Spinal Cord Injury WP2431,0.9863730305294117,0.4335126112759644,0.005948082967839441,"['COL4A1', 'GADD45A', 'APEX1', 'TNFSF13', 'MAPK1']",0.9996837755714765,0,0,5
395,Osteoblast differentiation WP4787,0.9875112595016647,0.39648416816689613,0.004982767302420586,"['FZD9', 'MAPK1', 'WNT9A', 'DLL3']",0.9996837755714765,0,0,4
396,Glycolysis and Gluconeogenesis WP534,0.9881013466749049,0.2172244822485207,0.0026001789833826118,['ALDOA'],0.9996837755714765,0,0,1
397,TGF-beta Receptor Signaling WP560,0.9895986131302438,0.21061950869643178,0.002202207959216566,['HRAS'],0.9996837755714765,0,0,1
398,Gastrin signaling pathway WP4659,0.9897411010686359,0.3853883535128902,0.003974080045071329,"['RPS6', 'MAPK1', 'HRAS', 'PTK2']",0.9996837755714765,0,0,4
399,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.99009099875317,0.28935356526030104,0.0028815049520809943,"['RYK', 'FZD9']",0.9996837755714765,0,0,2
400,"GPCRs, Class A Rhodopsin-like WP455",0.9904373968618371,0.4984821428571429,0.004789724696438358,"['CHRM3', 'GPR65', 'CHRM5', 'OR7A5', 'GPR37L1', 'OR6A2', 'DRD1', 'F2RL2', 'HCRTR1']",0.9996837755714765,0,0,9
401,IL-4 signaling pathway WP395,0.9909075508995971,0.20440306300034808,0.0018670252839519546,['MAPK1'],0.9996837755714765,0,0,1
402,IL-1 signaling pathway WP195,0.9920518326880378,0.198541842772612,0.0015843484922636378,['MAPK1'],0.9996837755714765,0,0,1
403,Lung fibrosis WP3624,0.9920518326880378,0.198541842772612,0.0015843484922636378,['SERPINA1'],0.9996837755714765,0,0,1
404,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.9920518326880378,0.198541842772612,0.0015843484922636378,['MAPK1'],0.9996837755714765,0,0,1
405,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.9920518326880378,0.198541842772612,0.0015843484922636378,['HRAS'],0.9996837755714765,0,0,1
406,Calcium Regulation in the Cardiac Cell WP536,0.9923237069289129,0.42858126879893466,0.003302607595840086,"['CHRM3', 'PKIB', 'GNG3', 'CHRM5', 'ATP1A4', 'RGS6']",0.9996837755714765,0,0,6
407,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.9930347820739168,0.27224568583910247,0.0019028852565555374,"['RYK', 'FZD9']",0.9996837755714765,0,0,2
408,Retinoblastoma gene in cancer WP2446,0.9930347820739168,0.27224568583910247,0.0019028852565555374,"['H2AFZ', 'SKP2']",0.9996837755714765,0,0,2
409,Endoderm differentiation WP2853,0.9931127911743844,0.36494869493972143,0.002522173243735702,"['TNRC6C', 'ACACA', 'AHDC1', 'NME1']",0.9996837755714765,0,0,4
410,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.9935413788251694,0.3937651739951443,0.0025514283431413444,"['NTRK2', 'SST', 'AVP', 'ALDOA', 'HDAC9']",0.9996837755714765,0,0,5
411,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.993700015082934,0.5511163056960213,0.00348300741695567,"['LAMA5', 'CSF3R', 'CAB39L', 'RPS6', 'ITGB2', 'VEGFB', 'ITGAE', 'PTK2', 'ACACA', 'FGF17', 'GNG10', 'GNG3', 'COL4A1', 'MAPK1', 'HRAS']",0.9996837755714765,0,0,15
412,Pathways Regulating Hippo Signaling WP4540,0.9937833343922664,0.32017094017094017,0.0019966082455607106,"['NTRK2', 'CDH13', 'CDH8']",0.9996837755714765,0,0,3
413,Mesodermal commitment pathway WP2857,0.9941278711172984,0.38929916980628815,0.0022927531777315285,"['EXT2', 'SETD2', 'RPL38', 'ACACA', 'AHDC1']",0.9996837755714765,0,0,5
414,"GPCRs, Other WP117",0.9945015012377202,0.2619164001508317,0.0014441208989768438,"['CHRM3', 'ADGRL2']",0.9996837755714765,0,0,2
415,Myometrial relaxation and contraction pathways WP289,0.9946532114674737,0.4114313435797923,0.0022057384672730215,"['PKIB', 'GNG3', 'GSTO1', 'CRH', 'IGFBP6', 'RGS6']",0.9996837755714765,0,0,6
416,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.9946910557007652,0.18280909374026783,0.0009731086776114799,['TNFRSF11B'],0.9996837755714765,0,0,1
417,Peptide GPCRs WP24,0.9953592903152315,0.17810271582460932,0.0008284467789648225,['HCRTR1'],0.9996837755714765,0,0,1
418,Ectoderm Differentiation WP2858,0.9958514811182543,0.34223796319175614,0.0014227338161068913,"['CTNND2', 'TNFRSF11B', 'CDH8', 'LY6E']",0.9996837755714765,0,0,4
419,Neural Crest Differentiation WP2064,0.9961509607396921,0.24780585809453315,0.0009556548353503616,"['HDAC9', 'DLL3']",0.9996837755714765,0,0,2
420,Cell cycle WP179,0.9963948640914646,0.29714285714285715,0.001073176021395468,"['GADD45A', 'SKP2', 'ANAPC11']",0.9996837755714765,0,0,3
421,Complement and Coagulation Cascades WP558,0.9969003729134686,0.16532826148210764,0.0005132518136393735,['SERPINA1'],0.9996837755714765,0,0,1
422,Joubert Syndrome WP4656,0.9972905195574769,0.16146621714600248,0.00043808331494384425,['PDE6G'],0.9996837755714765,0,0,1
423,Endochondral Ossification with Skeletal Dysplasias WP4808,0.9976315453308136,0.1577797202797203,0.00037413735398438475,['CTSV'],0.9996837755714765,0,0,1
424,Endochondral Ossification WP474,0.9976315453308136,0.1577797202797203,0.00037413735398438475,['CTSV'],0.9996837755714765,0,0,1
425,Ciliopathies WP4803,0.9976808189149675,0.377404332860903,0.0008762855157989311,"['DNAAF3', 'TBC1D32', 'TTC21B', 'CCNQ', 'CCDC28B', 'CNGB1']",0.9996837755714765,0,0,6
426,Male infertility WP4673,0.9985276077919542,0.21664507772020725,0.0003192215917524584,"['PEX10', 'LRWD1']",0.9996837755714765,0,0,2
427,Wnt signaling WP428,0.9986953696685107,0.21328930137220292,0.00027844536560717474,"['RYK', 'FZD9']",0.9996837755714765,0,0,2
428,Adipogenesis WP236,0.9988141876767052,0.25972222222222224,0.00030816456054329536,"['GADD45A', 'CELF1', 'DDIT3']",0.9996837755714765,0,0,3
429,PI3K-Akt signaling pathway WP4172,0.9989498760821147,0.47523885555355255,0.000499321909775442,"['LAMA5', 'NTRK2', 'CSF3R', 'RPS6', 'VEGFB', 'PTK2', 'FGF17', 'GNG10', 'GNG3', 'COL4A1', 'MAPK1', 'COL9A3', 'PIK3AP1', 'HRAS']",0.9996837755714765,0,0,14
430,Wnt signaling pathway and pluripotency WP399,0.9996837755714765,0.1174781867415505,3.715534749026056e-05,['FZD9'],0.9996837755714765,0,0,1
